TrialScientific reports2026

Heterologous RBMRNA-405 mRNA booster enhances humoral immunity post-inactivated COVID-19 vaccination: a randomized clinical trial in adults and older through 12 months.

Xiaolan Yong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.